The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
What's New at
  • Email Email
  • Glossary Glossary


What's the Next Big Question in HIV Treatment?

Myles Helfand,; Posted Jul 31, 4:04 p.m. ET

Now that a major study has concluded that the benefits of starting treatment immediately far outweighs the risks of delaying for all individuals living with HIV -- what's the next big question researchers should try to answer about HIV treatment?

Are U.S. Vaccine Rates Going Down Because Public Trust and Social Ties Are Eroding?

Charles McCoy, The Conversation; Posted Jul 31, 1:13 p.m. ET

Vaccines have been used safely and effectively for decades. So why is the American public -- or at least a significant segment of it -- now increasingly skeptical of mandatory school vaccinations?

Four Challenges We Have to Crack Before Immune Therapy Can Revolutionize How We Fight Cancer

Sri Krishna, The Conversation; Posted Jul 31, 12:57 p.m. ET

Within the last five years, a new class of drugs that uses our immune systems to fight cancer is gaining traction in cancer treatment. This is called "immunotherapy." Instead of killing cancer cells with radiation or chemotherapy, immunotherapy mobilizes the immune system to fight against cancer much like it does against bacteria and viruses.

CRISPR/Cas Gene-Editing Technique Holds Great Promise, but Research Moratorium Makes Sense Pending Further Study

Jeff Bessen, The Conversation; Posted Jul 31, 12:31 p.m. ET

CRISPR/Cas is a new technology that allows unprecedented control over the DNA code. It's sparked a revolution in the fields of genetics and cell biology, becoming the scientific equivalent of a household name by raising hopes about new ways to cure diseases.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?

Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?


Could HIV Prevention Pills Actually Increase Infection Risk by Cutting Condom Use?

Lisa McDaid and Ingrid Young, The Conversation; Posted Jul 31, 12:07 p.m. ET

Will people taking PrEP (pre-exposure prophylaxis) stop using condoms and could this actually lead to an increase in HIV and sexually transmitted infections (STIs)?

How to Get More Men Using Condoms -- Put the Pleasure Back Into Sex

Mark Limmer and Rachael Eastham, The Conversation; Posted Jul 31, 11:55 a.m. ET

Pleasure, excitement and intimacy are powerful drivers in young people's sexual decision making. But they are rarely considered when it comes to strategies for reducing the risk of sexually transmitted infections (STIs) or promoting condom use.

When It Comes to Older People and Sex, Doctors Put Their Heads in the Sand

Sharron Hinchliff, The Conversation; Posted Jul 31, 11:35 a.m. ET

There has been a societal shift in attitudes towards sexuality and aging, which is a step in the right direction. It enables us to move away from the taboo that surrounds sex after the age of 60 and the negative stereotyping of the sexuality of older adults.

This Week in HIV Research: New Drugs in Development; Cash Incentives for Prevention; Adherence Clubs; and More

Warren Tong,; Posted Jul 31, 10:23 a.m. ET

This week we're highlighting more of the research that was presented at IAS 2015, including study results on two new drugs in development, cash-incentive programs for prevention, and approaches at increasing treatment adherence.

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.


Despite Research Breakthroughs, an Anti-Aging Pill Is Still a Long Way Off

Sharon Horesh Bergquist, The Conversation; Posted Jul 31, 9:56 a.m. ET

A team of doctors and scientists made the case to regulators at the Food and Drug Administration (FDA) to consider approving anti-aging drugs as a new pharmaceutical class. Such a designation would treat aging as disease rather than a natural process.

Connections Between Black Lives Matter and the HIV Movement

Visual AIDS; Posted Jul 31, 9:28 a.m. ET

Since its inception in 2007, Black Lives Matter has been a lens through which to view American racism. Can we view the fight against HIV through that lens, as well?

When Time Can Cure What Meds Cannot

Visual AIDS; Posted Jul 31, 8:54 a.m. ET

How has time changed the meaning of living with HIV? In this analysis of an artist-made video, the writer discusses PTSD, the power of time and getting to live with HIV "casually."

A History of the Red Ribbon

Visual AIDS; Posted Jul 30, 4:47 p.m. ET

Why make art in response to AIDS? The people behind the red ribbon discuss their decision to make the iconic awareness symbol.

>> Browse Older Featured Stories


  • Email Email
  • Glossary Glossary
HIV/AIDS News Feed: Latest Headlines


More ...